COVID-19 and Advanced Practice Registered Nurses: Frontline Update

      Highlights

      • Advanced practice registered nurses (APRNs) are on the front line of treatment of coronavirus disease 2019 (COVID-19).
      • APRNs can help with physical and psychologic issues caused by COVID-19.
      • APRNs must regularly review updates on COVID-19 due to rapidly changing guidelines.
      • Vulnerable populations will face unique challenges from the pandemic.
      • COVID-19 affects the mental health of the general population and providers.

      Abstract

      Coronavirus disease 2019 (COVID-19) emerged in 2019 and rapidly became a global pandemic, infecting millions and killing hundreds of thousands. The disease altered the practices of hospitals, clinics, and patients. These changes have implications for advanced practice registered nurses (APRNs). APRNs must remain current on best practices for treatment and diagnosis of COVID-19 while being cognizant of changes to their scope of practice. As the pandemic continues, APRNs will remain on the front lines treating patients with COVID-19 while also caring for vulnerable populations within the community. To provide high-quality care, APRNs must use a multifaceted approach that heeds ongoing updates to evidence-based practice.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to The Journal for Nurse Practitioners
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Centers for Disease Control and Prevention
        Coronavirus Disease 2019 (COVID-19): Symptoms of Coronavirus.
        (Accessed May 3, 2020)
        • Garg S.
        • Kim L.
        • Whitaker M.
        • et al.
        Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 states, March 1-30, 2020.
        MMWR Morb Mortal Wkly Rep. 2020; 69: 458-464https://doi.org/10.15585/mmwr.mm6915e3
        • Recalcati S.
        Cutaneous manifestation in COVID-19: a first perspective.
        J Eur Acad Dermatol Venereol. 2020; 34: e212-e213https://doi.org/10.1111/jdv.16387
        • Centers for Disease Control and Prevention
        Coronavirus Disease 2019 (COVID-19): People Who Are at Higher Risk for Severe Illness.
        (Accessed May 4, 2020)
        • Centers for Disease Control and Prevention
        Coronavirus Disease 2019 (COVID-19): What to Do If You Get Sick?.
        (Accessed May 8, 2020)
        • Fraher E.P.
        • Pittman P.
        • Frogner B.K.
        • et al.
        Ensuring and sustaining a pandemic workforce.
        N Engl J Med. 2020; 382: 2181-2183https://doi.org/10.1056/NEJMp2006376
        • American Association of Nurse Practitioners
        Coronavirus Disease 2019 (COVID-19) Policy and Practice Updates.
        (Accessed May 12, 2020)
        • Centers for Medicare and Medicaid Services
        COVID-19 emergency declaration blanket waivers for health care providers.
        (Accessed June 14, 2020)
        • Livingston E.
        • Desai A.
        • Berkwits M.
        Sourcing personal protective equipment during the COVID-19 pandemic.
        JAMA. 2020; 323: 1912-1914https://doi.org/10.1001/jama.2020.5317
        • Dewey C.
        • Hingle S.
        • Goelz E.
        • Linzer M.
        Supporting clinicians during the COVID-19 pandemic.
        Ann Intern Med. 2020; 172: 752-753https://doi.org/10.7326/M20-1033
        • Blake H.
        • Bermingham F.
        • Johnson G.
        • Tabner A.
        Mitigating the psychological impact of COVID-19 on healthcare workers: a digital learning package.
        Int J Environ Res Public Health. 2020; 17: 2997https://doi.org/10.3390/ijerph17092997
        • Rosenbaum L.
        The untold toll—the pandemic’s effects on patients without COVID-19.
        N Engl J Med. 2020; 382: 2368-2371https://doi.org/10.1056/NEJMms2009984
        • Centers for Disease Control and Prevention
        Coronavirus Disease 2019 (COVID-19): Overview of Testing for SARS-CoV-2.
        (Accessed May 3, 2020)
        • Loeffelholz M.J.
        • Tang Y.W.
        Laboratory diagnosis of emerging human coronavirus infections—the state of the art.
        Emerg Microbes Infect. 2020; 9: 747-756https://doi.org/10.1080/22221751.2020.1745095
        • Wang W.
        • Xu Y.
        • Gao R.
        • et al.
        Detection of SARS-CoV-2 in different types of clinical specimens.
        JAMA. 2020; 323: 1843-1844https://doi.org/10.1001/jama.2020.3786
        • Chen C.
        • Gao G.
        • Xu Y.
        • et al.
        SARS-CoV-2-positive sputum and feces after conversion of pharyngeal samples in patients with COVID-19.
        Ann Intern Med. 2020; 172: 832-834https://doi.org/10.7326/M20-0991
        • US Food and Drug Administration
        Emergency Use Authorizations for Medical Devices.
        (Accessed May 1, 2020)
        • US Food and Drug Administration
        Coronavirus (COVID-19) Update: Daily Roundup.
        (Accessed May 1, 2020)
        • Zhao J.
        • Yuan Q.
        • Wang H.
        • et al.
        Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019.
        Clin Infect Dis. 2020; : ciaa344https://doi.org/10.1093/cid/ciaa344
        • Johns Hopkins University School of Public Health, Center for Health Security
        Serology-based tests for COVID-19.
        (Accessed April 30, 2020)
        • National Library of Medicine
        ClinicalTrials.gov. 1266 Studies found for: Interventional Studies | COVID.
        (Accessed May 1, 2020)
        • National Institutes of Health
        COVID-19 Treatment Guidelines—Introduction.
        (Accessed May 1, 2020)
      1. National Institutes of Health COVID-19 Treatment Guidelines—Pharmacologic interventions.
        (Accessed April 29, 2020)
        • Shah S.
        • Das S.
        • Jain A.
        • Misra D.P.
        • Negi V.S.
        A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
        Int J Rheum Dis. 2020; 23: 613-619https://doi.org/10.1111/1756-185X.13842
        • National Institutes of Health COVID-19 Treatment Guidelines
        Potential Antiviral Drugs Under Evaluation for the Treatment of COVID-19.
        (Accessed April 30, 2020)
        • National Institutes of Health
        COVID-19 Treatment Guidelines—Therapeutic Options for COVID-19 Currently Under Investigation.
        (Accessed May 1, 2020)
        • US Food and Drug Administration
        Recommendations for Investigational COVID-19 Convalescent Plasma.
        (Accessed May 1, 2020)
        • National Institutes of Health
        NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19.
        (Accessed May 1, 2020)
        • Wang Y.
        • Zhang D.
        • Du G.
        • et al.
        Remdesivir in adults with severe COVID-19: a randomized, double-blind placebo-controlled, multicenter trial.
        Lancet. 2020; 395: 1569-1578https://doi.org/10.1016/S0140-6736(20)31022-9
        • Centers for Disease Control and Prevention
        Coronavirus Disease 2019 (COVID-19): How to Protect Yourself & Others.
        (Accessed May 3, 2020)
        • Zhang P.
        • Zhu L.
        • Cai J.
        • et al.
        Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19.
        Circ Res. 2020; 126: 1671-1681https://doi.org/10.1161/CIRCRESAHA.120.317134
        • Green W.D.
        • Beck M.A.
        Obesity impairs the adaptive immune response to influenza virus.
        Ann Am Thorac Soc. 2017; 14: S406-S409https://doi.org/10.1513/AnnalsATS.201706-447AW
        • Qin C.
        • Zhou L.
        • Hu Z.
        • et al.
        Dysregulation of immune response in patients with COVID-19 in Wuhan, China.
        (Accessed May 1, 2020)
        • Grant W.B.
        • Lahore H.
        • McDonnell S.L.
        • et al.
        Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths.
        Nutrients. 2020; 12: 988https://doi.org/10.3390/nu12040988
        • Martineau A.R.
        • Jolliffe D.A.
        • Hooper R.L.
        • et al.
        Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data.
        BMJ. 2017; 356: i6583https://doi.org/10.1136/bmj.i6583
        • Jordan R.E.
        • Adab P.
        • Cheng K.K.
        COVID-19: risk factors for severe disease and death.
        BMJ. 2020; 368: m11982https://doi.org/10.1136/bmj.m1198
        • Bedford J.
        • Enria D.
        • Giesecke J.
        • et al.
        COVID-19: towards controlling of a pandemic.
        Lancet. 2020; 395: 1015-1018https://doi.org/10.1016/S0140-6736(20)30673-5
        • Wang H.
        • Li T.
        • Gauthier S.
        • et al.
        Coronavirus epidemic and geriatric mental healthcare in China: how a coordinated response by professional organizations helped older adults during an unprecedented crisis.
        Int Psychogeriatr. 2020; ([published online ahead of print, Apr 9, 2020]): 1-4https://doi.org/10.1017/S1041610220000551
        • Banskota S.
        • Healy M.
        • Goldberg E.M.
        15 smartphone apps for older adults to use while in isolation during the COVID-19 pandemic.
        West J Emerg Med. 2020; 21: 514-525https://doi.org/10.5811/westjem.2020.4.47372
        • Centers for Disease Control and Prevention
        Coronavirus Disease 2019 (COVID-19): Preparing for COVID-19 in Nursing Homes.
        (Accessed May 3, 2020)
        • Bradbury-Jones C.
        The domestic paradox: the consequences of COVID-19 on domestic violence.
        J Clin Nurs. 2020; 29: 2047-2049https://doi.org/10.1111/jocn.15296
        • Page K.R.
        • Venkataramani M.
        • Beyrer C.
        • Polk S.
        Undocumented U.S. immigrants and COVID-19.
        N Engl J Med. 2020; 382: e62https://doi.org/10.1056/NEJMp2005953
        • Regan A.K.
        • de Klerk N.
        • Moore H.C.
        • et al.
        Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: a retrospective cohort study.
        Vaccine. 2016; 34: 3649-3656https://doi.org/10.1016/j.vaccine.2016.05.032
        • Poon L.C.
        • Yang H.
        • Kapur A.
        • et al.
        Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: information for healthcare professionals.
        Int J Gynaecol Obstet. 2020; 149: 273-286https://doi.org/10.1002/ijgo.13156
        • Centers for Disease Control and Prevention
        Coronavirus Disease 2019 (COVID-19): COVID-19 in Racial and Ethnic Minority Groups.
        (Accessed June 13, 2020)
        • Holmes E.A.
        • O’Connor R.C.
        • Perry V.H.
        • et al.
        Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science.
        Lancet Psychiatry. 2020; 7: 547-560https://doi.org/10.1016/S2215-0366(20)30168-1
        • Zhou X.
        • Snoswell C.L.
        • Harding L.E.
        • et al.
        The role of telehealth in reducing the mental health burden from COVID-19.
        Telemed J E Health. 2020; 26: 377-379https://doi.org/10.1089/tmj.2020.0068
        • Buerhaus P.I.
        • Auerrbach D.I.
        • Staiger D.O.
        Older clinicians and the surge in novel coronavirus disease (COVID-19).
        JAMA. 2020; 323: 1777-1778https://doi.org/10.1001/jama2020.4978
        • Kumaraiah D.
        • Yip N.
        • Ivascu N.
        • Hill L.
        Innovative ICU physician care models: COVID-19 pandemic at New York Presbyterian.
        NEJM Catalyst Innovations in Care Delivery. April 28, 2020; https://doi.org/10.1056/CAT.20.0158

      Biography

      Ana Diez-Sampedro, PhD, FNP-BC, Arturo Gonzalez, DNP, ANP-BC, CWCN-AP, Victor Delgado, DNP, ANP-BC, Monica Flowers, DNP, FNP-BC, Tatayana Maltseva, PhD, PMHNP-BC, and Maria Olenick, PhD, FNP-BC, FAAN, are affiliated with the Nicole Wertheim College of Nursing & Health Sciences, Florida International University, Miami, Florida, and Ana Diez Sampedro can be contacted at [email protected] .

      Linked Article

      • Letter to the Editor
        The Journal for Nurse PractitionersVol. 17Issue 3
        • Preview
          In response to the article by Diez-Sampedro et al, “COVID-19 and Advanced Practice Registered Nurses: Frontline Update,”1 published in the September 2020 edition of The Journal for Nurse Practitioners, the authors provide factors that advanced practice registered nurses (APRNs) have been challenged with during the coronavirus disease 2019 (COVID-19) pandemic. They also deliver a synopsis of the essential clinical information health care providers should be knowledgeable of regarding the COVID-19 pandemic (eg, symptoms, testing, treatment challenges, patient education).
        • Full-Text
        • PDF
      • Letter to the Editor
        The Journal for Nurse PractitionersVol. 17Issue 2
        • Preview
          In response to the article by Diez-Sampedro et al, “COVID-19 and Advanced Practice Registered Nurses: Frontline Update,”1 published in the September 2020 edition of The Journal for Nurse Practitioners, the authors provide factors that advanced practice registered nurses (APRNs) have been challenged with during the coronavirus disease 2019 (COVID-19) pandemic. They also deliver a synopsis of the essential clinical information health care providers should be knowledgeable of regarding the COVID-19 pandemic (eg, symptoms, testing, treatment challenges, patient education).
        • Full-Text
        • PDF